-
Zepbound & Mounjaro (Tirzepatide) Doctor in Denver — Dual GLP-1/GIP Medication
20% Average Weight Loss | 50 Pounds
Tirzepatide — sold as Mounjaro® for diabetes and Zepbound® for weight loss — is the most effective GLP-1 medication on the market today. In clinical trials, patients lost an average of 20–22% of body weight over 72 weeks, compared to 12–15% with semaglutide.
At Clinical Nutrition Center in Greenwood Village, our board-certified obesity medicine doctors prescribe tirzepatide as part of a comprehensive, medically supervised weight loss program.
Serving Denver, Aurora, Parker, Castle Rock, and surrounding Colorado communities.
What Is Tirzepatide?
Tirzepatide is a dual GLP-1 and GIP receptor agonist — meaning it activates two hormone pathways instead of one. GIP is a second incretin hormone that further reduces appetite and improves how your body stores and uses fat.
It is FDA-approved under two brand names:
- Zepbound® — FDA-approved for chronic weight management
- Mounjaro® — FDA-approved for Type 2 diabetes (used off-label for weight loss)
Both contain the same active ingredient (tirzepatide). The difference is only the indication and dosing.
Tirzepatide vs. Semaglutide — Which Is Better?
| Tirzepatide (Zepbound) | Semaglutide (Wegovy) | |
|---|---|---|
| Average weight loss | 20–22% | 15% (oral / 2.4 mg), 22% (7.2 mg) |
| Hormone targets | GLP-1 + GIP | GLP-1 only |
| Dosing | Weekly injection | Weekly injection or Daily Pill |
| Side effects | Similar to semaglutide; diarrhea most common | Nausea, constipation, fatigue |
| Cost | $299 – $450/month | $199 – $399/month |
Neither is universally “better” — tirzepatide produces greater weight loss on average, but semaglutide works well for patients who respond to it and costs less. Our doctors help you decide based on your health history and goals.
Frequently Asked Questions — Zepbound Denver
How much does Zepbound cost in Denver?
$299 – $449 /month depending on dose. If you have insurance coverage, it is often closer to $25 / month. We provide prior authorization support for insurance coverage.
Do I need diabetes to use Mounjaro?
No. Mounjaro is FDA-approved for Type 2 diabetes but is commonly prescribed off-label for weight loss. Our doctors evaluate each patient individually.
Which is better — Zepbound or Wegovy?
Tirzepatide (Zepbound) produces greater average weight loss in trials. Semaglutide (Wegovy) is still highly effective and less expensive. Our doctors help you weigh the options based on your health profile, goals, and budget.
What are the side effects of tirzepatide?
Nausea, vomiting, constipation, diarrhea, and reduced appetite are the most common — usually mild and dose-dependent. We start at low doses to minimize side effects.
How long do I stay on the medication?
Most patients stay on long-term. Weight regain is common if the medication is stopped abruptly. We work with you to make a plan that fits your life.
Do you offer compounded tirzepatide?
No we do not offer compounded tirzepatide for patients. The FDA no longer allows sales of compounded tirzepatide from 503b pharmacies.